SS
Samuel Scofield
Senior Associate at Good Growth Capital
New York, New York
Overview
Samuel Scofield is currently a Senior Associate at Good Growth Capital, where he focuses on investing in life sciences companies at various stages, including Series A and Seed, across sectors such as Consumer Health, BioTech, and Digital Health. With a background in strategy consulting and previous roles at L.E.K. Consulting and Prescient Healthcare Group, Samuel brings expertise in evaluating and supporting innovative healthcare startups, while also serving as a Board Observer for companies like Spiro Robotics and VenoStent, Inc.
Work Experience
Senior Associate
2023 - Current
Associate
2022 - 2023
Investing in early-stage life sciences companies Therapeutics: AdipoPharma, Tevard Biosciences Medical devices: Avisi Technologies, Coaptech, Pleural Dynamics, Spiro Robotics, Venostent Diagnostics: AOA Dx Biomanufacturing: Aralez Bio Ag-Biotech: Robigo
Good Growth Capital invests in early-stage transformative science- and technology-based companies
Board Observer
2023
Board Observer
2023
Board Observer
2023
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
Raised $29,818,706.00 from Good Growth Capital, Norwest Venture Partners, IAG Capital Partners, Creative Ventures, SNR.vc, TMC Venture Fund, IAG Capital Partners, Alumni Ventures and Baylor Angel Network.
Associate
2022 - 2022
Senior Analyst, Advisory
2021 - 2022
Analyst, Advisory
2020 - 2021
Analyst Intern, Advisory
2020 - 2020